Memantine for the treatment of mild and mild-to-moderate Alzheimer's disease
Details for Australian Patent Application No. 2005204358 (hide)
International Classifications
Event Publications
27 July 2006 PCT application entered the National Phase
PCT publication WO2005/067908 Priority application(s): WO2005/067908
4 September 2008 Application Accepted
Published as AU-B-2005204358
8 January 2009 Standard Patent Sealed
3 December 2009 Offer to Surrender
Merz Pharma GmbH & Co. EckenKGaA heimer Landstrasse 100 , D-60318 Frankfurt , the Patentee of Letters Patent 2005204358 dated 18.12.2008 for an invention titled ' Memantine for the treatment of mild and mild-to-moderate Alzheimer's disease' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.
4 February 2010 Innovation Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005204359-Pothole protection mechanism
2005204347-Kit and composition of imidazole with enhanced biovailability
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser